Population Council Contraception Development Research Center Administrative Core

管理核心-摘要 人口理事会（PC）P50避孕发展研究中心将召集产品专家， 开发（包括设计、配方、制造和测试）、社会行为和临床科学， 和监管事务在PC和我们的学术合作伙伴，以推动我们的多用途 预防技术（MPT）阴道环（IVR），简称CZL-IVR，以满足妇女的需求 通过提供非激素避孕和性传播感染/艾滋病毒预防以及优化阴道健康，在全球范围内实现这一目标。 行政核心（AC）将成为P50中心的核心，提供科学，行政和管理服务。 行政领导，分配资源，并影响研究的优先事项。AC将作为 主要的后勤、监督和运营驱动程序，确保P50中心的顺利运作。交流 将与我们的外部和社区咨询委员会一起实施年度战略规划流程， 持续进行必要的审查和调整，促进P50项目之间的团队合作， 以及项目和P50中心整体的日常支持。AC将确保我们科学的严谨性， 提供监管监督和支持以及数据管理和统计专业知识。此外，委员会认为， AC将提供培训机会和试点赠款资金，以支持年轻科学家和早期阶段 研究人员致力于发展以避孕和性传播感染/艾滋病毒预防为重点的职业。AC将利用 其多学科专家团队的广泛技能，知识和专业知识以及数十年的成功经验， 避孕产品开发在PC的生物医学研究中心（CBR）建立P50中心 并支持其活动，以推进我们创新的非激素MPT CZL-IVR。

ADMINISTRATIVE CORE – ABSTRACT The Population Council (PC) P50 Contraception Development Research Center will convene experts in product development (including design, formulation, manufacture, and testing), social-behavioral and clinical science, and regulatory affairs within PC and our academic partners to advance the development our multipurpose prevention technology (MPT) intravaginal ring (IVR), referred to as the CZL-IVR, to meet the needs of women globally by providing non-hormonal contraception and STI/HIV prevention as well as optimizing vaginal health. The Administrative Core (AC) will be at the heart of the P50 Center, providing scientific, executive, and administrative leadership, allocating resources, and influencing research priorities. The AC will serve as the primary logistical, supervisory, and operational driver, ensuring smooth functioning of the P50 Center. The AC will implement an annual strategic planning process with our external and community advisory committees, with ongoing review and adjustments as necessary, promotion of collaborative teamwork across the P50 projects, and day-to-day support of the projects and P50 Center overall. The AC will ensure rigor of our science by providing regulatory oversight and support as well as data management and statistical expertise. Furthermore, the AC will provide training opportunities and pilot grant funding to support young scientists and early stage investigators developing careers focusing on contraception and STI/HIV prevention. The AC will leverage the extensive skills, knowledge, and expertise of its multidisciplinary team of experts and the decades of successful contraceptive product development at PC’s Center of Biomedical Research (CBR) to establish the P50 Center and support its activities in order to advance our innovative non-hormonal MPT CZL-IVR.